Mitindomide

Star0

DB20591ExperimentalSmall molecule

Mitindomide is a small molecule drug. Mitindomide has a monoisotopic molecular weight of 272.08 Da.

Mechanism: Pharmacologically active on DNA topoisomerase 2
Curator reviewed
Formula / weight: C₁₄H₁₂N₂O₄ · 272.26 g/mol (avg)
Code names: NSC-284356

Resolves to

Compound

UNIIDK61ZER6T7CAS10403-51-7ChEMBLCHEMBL473100ChEBI748904PubChem66362

Structure

InChIKeyDRCJGCOYHLTVNR-ZUIZSQJWSA-NSMILES[H][C@]12[C@H]3C=C[C@@H]([C@@]1([H])[C@]1([H])C(=O)NC(=O)[C@]21[H])[C@]1([H])C(=O)NC(=O)[C@]31[H]

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Mitindomide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account